6188-43-8Relevant articles and documents
Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid
McKenna, Charles E.,Kashemirov, Boris A.,B?azewska, Katarzyna M.,Mallard-Favier, Isabelle,Stewart, Charlotte A.,Rojas, Javier,Lundy, Mark W.,Ebetino, Frank H.,Baron, Rudi A.,Dunford, James E.,Kirsten, Marie L.,Seabra, Miguel C.,Bala, Joy L.,Marma, Mong S.,Rogers, Michael J.,Coxon, Fraser P.
, p. 3454 - 3464 (2010)
3-(3-Pyridyl)-2-hydroxy-2-phosphonopropanoic acid (3-PEHPC, 1) is a phosphonocarboxylate (PC) analogue of 2-(3-pyridyl)-1- hydroxyethylidenebis(phosphonic acid) (risedronic acid, 2), an osteoporosis drug that decreases bone resorption by inhibiting farnesyl pyrophosphate synthase (FPPS) in osteoclasts, preventing protein prenylation. 1 has lower bone affinity than 2 and weakly inhibits Rab geranylgeranyl transferase (RGGT), selectively preventing prenylation of Rab GTPases. We report here the synthesis and biological studies of 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2- phosphonopropionic acid (3-IPEHPC, 3), the PC analogue of minodronic acid 4. Like 1, 3 selectively inhibited Rab11 vs. Rap 1A prenylation in J774 cells, and decreased cell viability, but was 33-60 × more active in these assays. After resolving 3 by chiral HPLC (>98% ee), we found that (+)-3-E1 was much more potent than (-)-3-E2 in an isolated RGGT inhibition assay, ~17 × more potent (LED 3 μM) than (-)-3-E2 in inhibiting Rab prenylation in J774 cells and >26× more active in the cell viability assay. The enantiomers of 1 exhibited a 4-fold or smaller potency difference in the RGGT and prenylation inhibition assays.
Iodine-mediated aminohalogenation-oxidation to synthesize 2-fluoroalkyl imidazole derivatives
Li, Shan,Liang, Jian,Liu, Xiaofeng,Xian, Liqing,Du, Mingxu
, p. 1041 - 1053 (2020/10/02)
A simple and efficient method of iodine-mediated aminohalogenation-oxidation of fluorinated N’-propargyl amidines to synthesize 2-fluoroalkyl imidazole-5-carbaldehydes was developed. This method showed good functional group compatibility and wide substrat
Novel method for constructing imidazolyl[1,2-a]pyridyl-3-aldehyde by taking DMF as formylation reagent
-
Paragraph 0020-0029, (2019/11/12)
The invention discloses a novel method for constructing imidazolyl[1,2-a]pyridyl-3-aldehyde in one step by taking DMF (N,N-dimethylformamide) as a formylation reagent. According to the method, imidazolyl[1,2-a]pyridine serves as a reactant, and the imidazolyl[1,2-a]pyridyl-3-aldehyde is constructed in one step by taking the DMF (N,N-dimethylformamide) as the formylation reagent. According to the method disclosed by the invention, the means of synthesis is novel, the reaction conditions are mild, the reaction reagent is cheap and readily available, the N,N-dimethylformamide can serve as a reaction solvent and also can serve as a formylation reagent, and thus, the method is in line with development requirements of green chemistry.
Microwave-assisted synthesis of 3-formyl substituted imidazo[1,2-a]pyridines
Kusy, Damian,Maniukiewicz, Waldemar,B?a?ewska, Katarzyna M.
supporting information, (2019/10/16)
An efficient, metal-free method for the synthesis of 3-formyl imidazo[1,2-a]pyridines is reported. The method utilises commercially available substrates and features a broad substrate scope. The intermediate enamine was isolated and a plausible reaction mechanism proposed.